]>
IRCT20150317021497N9 IRCT 2023-12-20 Rafsanjan University of Medical Sciences The effect of isosorbide on the duration of Renal stone free Investigating the effect of isosorbide dinitrate on the duration of kidney stone free after Extra Corporeal Shock Wake Lithotripsy 2023-12-22 anticipated 176 Complete https://irct.ir/trial/73850 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random method and after maximum effort for matching based on age, sex, weight and size of the stone, Blinding description: The data analyst did not know about the grouping. 3 Calculus of kidney. Intervention 1: Intervention group: Administration of isosorbide. Intervention 2: Control group: Placebo administration. Yes - There is a plan to make this available What will be shared: All data is potentially shareable after de-identifying individuals When: The access period starts 6 months after the results are published To whom: The data will be available only to researchers working in academic and scientific institutions. Conditions: To receive the data, a valid letter from the highest authority of the person's university is required. Any analysis on the data will be done with the knowledge and permission of the researchers. Where to obtain: Vice Chancellery for Research & Technology of Rafsanjan University of Medical Sciences How to obtain: After submitting the request to the Research and Technology Vice-Chancellor of Rafsanjan University of Medical Sciences, the review process will begin. After reviewing the application and approval, the data will be provided to the applicant. Comments:
public Reza Vazirinejad
Imam Ali Blvd.-Central Organization-Building No. 3, Research and Technology Vice-Chancellor
Rafsanjan Iran (Islamic Republic of) 7717933777 +98 34 3428 0086 vcrt@rums.ac.ir Rafsanjan University of Medical Sciences scientific Alireza Nazari
Moradi hospital, Shohada ST
Rafsanjan Iran (Islamic Republic of) 7713961151 +98 34 3426 0080 drnazari57@gmail.com Rafsanjan University of Medical Sciences Iran (Islamic Republic of) Informed consent to participate in the study weight under 100 kg stone size up to 20 mm no limit no limit Both Moderate and severe hydronephrosis History of taking smooth muscle relaxant drugs History of taking smooth muscle relaxant drugs History of stone removal History of kidney surgery history of Extra Corporeal Shock Wake Lithotripsy History of renal failure N20.0 Calculus of kidney Treatment - Drugs Placebo Intervention group: Administration of isosorbide Control group: Placebo administration Duration of stone free. Timepoint: After prescribing the drug. Method of measurement: check list. Rafsanjan University of Medical Sciences Approved 2019-02-02 Ethics committee of Rafsanjan University of Medical Sciences Imam Ali Blvd.-Central Organization-Building No. 3, Research and Technology Vice-Chancellor Rafsanjan Kerman Iran (Islamic Republic of)